0001645113-20-000124.txt : 20200903
0001645113-20-000124.hdr.sgml : 20200903
20200903163710
ACCESSION NUMBER: 0001645113-20-000124
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200901
FILED AS OF DATE: 20200903
DATE AS OF CHANGE: 20200903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Pritesh
CENTRAL INDEX KEY: 0001744884
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 201159639
MAIL ADDRESS:
STREET 1: C/O NOVOCURE INC.
STREET 2: 20 VALLEY STREAM PARKWAY, SUITE 300
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
wf-form4_159916541528809.xml
FORM 4
X0306
4
2020-09-01
0
0001645113
NovoCure Ltd
NVCR
0001744884
Shah Pritesh
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Commercial Officer
Restricted Share Units
2020-09-01
4
A
0
1968
0
A
102986
D
Ordinary Shares
2020-09-02
4
P
0
4200
85.0129
D
98786
D
Options to Buy Ordinary Shares
84.68
2020-09-01
4
A
0
3779
0
A
2030-08-31
Ordinary Shares
3779.0
3779
D
Represents restricted share units that are scheduled to vest in equal installments on September 1, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates.
On September 2, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 4200 shares in multiple trades at prices ranging from $85.00 to $85.02. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
Options to buy 3,779 ordinary shares will vest and become exercisable in equal installments on each of September 1, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates.
By: /s/ Steven Robbins, Attorney in fact for Pritesh Shah
2020-09-03